Dergiler / The Anatolian Journal of Cardiology / 2018 / Cilt: 20 - Sayı: 4

Modeling the burden of cardiovascular disease in Turkey

Sayfa
235–240
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-carecosts, as well as on society in the form of lost productivity.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: This study aims to estimate the current and future burden of cardiovascular diseases (CVD) in Turkey.Methods: A burden-of-disease model was developed that included inputs on population growth, prevalence, and incidence of ischemic disease(IHD) and cerebrovascular disease (CeVD), prevalence of modifiable risk factors, mortality rates, and relationship between risk factors and IHD/CeVD.
📊
Temel Bulgular & Veri:Direct costs to the public health-care system and indirect costs from lost production due to premature mortality, hospitalizations, disability, and absenteeism were considered.Results: We estimated that in 2016, 3.4 million Turkish adults were living with CVD, including 2.5 million affected by IHD, and 0.9 million by CeVD.This prevalence is projected to increase to 5.4 million by 2035.
💡
Sonuç & Katkı:This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-carecosts, as well as on society in the form of lost productivity.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: This study aims to estimate the current and future burden of cardiovascular diseases (CVD) in Turkey.Methods: A burden-of-disease model was developed that included inputs on population growth, prevalence, and incidence of ischemic disease(IHD) and cerebrovascular disease (CeVD), prevalence of modifiable risk factors, mortality rates, and relationship between risk factors and IHD/CeVD. Direct costs to the public health-care system and indirect costs from lost production due to premature mortality, hospitalizations, disability, and absenteeism were considered.Results: We estimated that in 2016, 3.4 million Turkish adults were living with CVD, including 2.5 million affected by IHD, and 0.9 million by CeVD.This prevalence is projected to increase to 5.4 million by 2035. The economic burden of CVD was estimated at US$10.2 billion in 2016, projectedto increase twofold to US$19.4 billion by 2035.Conclusion: Our study confirms that the current burden of CVD is significant, and that it is projected to increase at a steep rate over the next twodecades. This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-carecosts, as well as on society in the form of lost productivity.

🔖

Bu Makaleye Atıf Yap

BALBAY, Y., ARPIN, I. G., MALHAN, S., ÖKSÜZ, M. E., SUTHERLAND, G., DOBRESCU, A., VILLA, G., ERTUĞRUL, G., HABIB, M. (2018). Modeling the burden of cardiovascular disease in Turkey. The Anatolian Journal of Cardiology, Cilt: 20 - Sayı: 4, 235–240. https://ajindex.com/articles/365287

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. World Health Organization. Cardiovascular Diseases. 2015; Accessed February 22, 2016.
  2. Institute for Health Metrics and Evaluation. GBD Profile: Turkey 2010
  3. Dinç G, Sözmen K, Gerçeklioğlu G, Arık H, Critchley J, Unal B. Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008. BMC Public Health 2013; 13: 896
  4. World Health Organization. Estimated DALYs ('000) by cause, sex and WHO Member State. Accessed August 30, 2017. http://www.who.int/ healthinfo/global_burden_disease/estimates/en/index2.html
  5. The World Bank. Death rate, crude (per 1,000 people). Accessed August 30, 2017. http://data.worldbank.org/indicator/SP.DYN.CDRT. IN?locations=TR
  6. D'Addato AV, Vignoli V, Yavuz, S. Towards smaller family size in Egypt, Morocco and Turkey: overall change over time or socio-economic compositional effect? Rostock; 2007
  7. Carter S, Taylor D, Kanavos P, Grimaccia F, Tordrup D, Tatar M. Transforming Health in Turkey: 21st Century Opportunities. UCL School of Pharmacy 2012; 1-23
  8. Sozmen K, Unal B. Socioeconomic Inequalities in Non-Communicable Diseases and Self Assessed Health in Turkey. Iran J Public Health 2014; 43: 736-48
  9. Ünal B, Ergör G, Dinç Horasan G, Kalaça, S, Sözmen, K. Chronic Diseases and Risk Factors Survey in Turkey. Ankara: Anıl Matbaa Ltd. Şti 2013; 69-89
  10. Arıcı M, Birdane A, Güler K, Yıldız BO, Altun B, Ertürk S, et al. Turkish Hypertension Consensus Report. Turk Kardiyol Dern Ars 2015; 43: 402-9
  11. Satman I. TURDEP-II Sonuçları. 2011
  12. Institute of Medicine. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health: Washington, DC: The National Academies Press; 2010
  13. Checkoway H, Pearce N, Kriebel D. Research Methods in Occupational Epidemiology. Oxford University Press; New York 2004
  14. The World Bank. Health Nutrition and Population Statistics: Population estimates and projections. Accessed July 15, 2016. http:// databank.worldbank.org/data/reports.aspx?source=Health%20Nutrition%20and%20Population%20Statistics:%20Population%20estimates%20and%20projections
  15. Onat A, Senocak MS, Surdum-Avci G, Ornek E. Prevalence of coronary heart disease in Turkish adults. Int J Cardiol 1993; 39: 23-31
  16. Ozturk Y, Demir C, Gursoy K, Koselerli R. Analysis of Stroke Statistics In Turkey. ISPOR 18th Annual European Congress Research Abstracts Research Abstracts 2015; 18: A402
  17. World Health Organization. WHO Mor